162 related articles for article (PubMed ID: 38203410)
1. Molecular Dynamics Investigations of Human DNA-Topoisomerase I Interacting with Novel Dewar Valence Photo-Adducts: Insights into Inhibitory Activity.
Di Martino J; Arcieri M; Madeddu F; Pieroni M; Carotenuto G; Bottoni P; Botta L; Castrignanò T; Gabellone S; Saladino R
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203410
[TBL] [Abstract][Full Text] [Related]
2. Lignin Nanoparticles Deliver Novel Thymine Biomimetic Photo-Adducts with Antimelanoma Activity.
Gabellone S; Piccinino D; Filippi S; Castrignanò T; Zippilli C; Del Buono D; Saladino R
Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35055101
[TBL] [Abstract][Full Text] [Related]
3. Potential Inhibitors of Monkeypox Virus Revealed by Molecular Modeling Approach to Viral DNA Topoisomerase I.
Hu X; An S; Chu J; Liang B; Liao Y; Jiang J; Lin Y; Ye L; Liang H
Molecules; 2023 Feb; 28(3):. PubMed ID: 36771105
[TBL] [Abstract][Full Text] [Related]
4. The modulation of topoisomerase I-mediated DNA cleavage and the induction of DNA-topoisomerase I crosslinks by crotonaldehyde-derived DNA adducts.
Dexheimer TS; Kozekova A; Rizzo CJ; Stone MP; Pommier Y
Nucleic Acids Res; 2008 Jul; 36(12):4128-36. PubMed ID: 18550580
[TBL] [Abstract][Full Text] [Related]
5. Benzo[a]pyrene diol epoxide adducts in DNA are potent suppressors of a normal topoisomerase I cleavage site and powerful inducers of other topoisomerase I cleavages.
Pommier Y; Kohlhagen G; Pourquier P; Sayer JM; Kroth H; Jerina DM
Proc Natl Acad Sci U S A; 2000 Feb; 97(5):2040-5. PubMed ID: 10688881
[TBL] [Abstract][Full Text] [Related]
6. Identification of N-(3-(methyl(3-(orotic amido)propyl)amino)propyl) oleanolamide as a novel topoisomerase I catalytic inhibitor by rational design, molecular dynamics simulation, and biological evaluation.
Zeng H; Xie H; Ma Q; Zhuang Y; Luo B; Liao M; Nie H; He J; Tang Z; Zhang S
Bioorg Chem; 2023 Oct; 139():106734. PubMed ID: 37473480
[TBL] [Abstract][Full Text] [Related]
7. Mechanistic studies of the modulation of cleavage activity of topoisomerase I by DNA adducts of mono- and bi-functional PtII complexes.
Malina J; Vrana O; Brabec V
Nucleic Acids Res; 2009 Sep; 37(16):5432-42. PubMed ID: 19589806
[TBL] [Abstract][Full Text] [Related]
8. Platinated DNA adducts enhance poisoning of DNA topoisomerase I by camptothecin.
van Waardenburg RC; de Jong LA; van Eijndhoven MA; Verseyden C; Pluim D; Jansen LE; Bjornsti MA; Schellens JH
J Biol Chem; 2004 Dec; 279(52):54502-9. PubMed ID: 15471886
[TBL] [Abstract][Full Text] [Related]
9. Interaction of DNA topoisomerase 1 with DNA intermediates and proteins of base excision repair.
Lebedeva NA; Rechkunova NI; Agama K; Pommier Y; Lavrik OI
Biochemistry (Mosc); 2009 Nov; 74(11):1278-84. PubMed ID: 19916945
[TBL] [Abstract][Full Text] [Related]
10. TOP1 CAD-seq: A protocol to map catalytically engaged topoisomerase 1 in human cells.
Kuzin V; Wiegard A; Cameron DP; Baranello L
STAR Protoc; 2022 Sep; 3(3):101581. PubMed ID: 35942340
[TBL] [Abstract][Full Text] [Related]
11. Exploring DNA topoisomerase I ligand space in search of novel anticancer agents.
Drwal MN; Agama K; Wakelin LP; Pommier Y; Griffith R
PLoS One; 2011; 6(9):e25150. PubMed ID: 21966440
[TBL] [Abstract][Full Text] [Related]
12. Differential stabilization of eukaryotic DNA topoisomerase I cleavable complexes by camptothecin derivatives.
Tanizawa A; Kohn KW; Kohlhagen G; Leteurtre F; Pommier Y
Biochemistry; 1995 May; 34(21):7200-6. PubMed ID: 7766631
[TBL] [Abstract][Full Text] [Related]
13. Human topoisomerase I inhibition: docking camptothecin and derivatives into a structure-based active site model.
Laco GS; Collins JR; Luke BT; Kroth H; Sayer JM; Jerina DM; Pommier Y
Biochemistry; 2002 Feb; 41(5):1428-35. PubMed ID: 11814334
[TBL] [Abstract][Full Text] [Related]
14. Trapping of human DNA topoisomerase I by DNA structures mimicking intermediates of DNA repair.
Lebedeva N; Rechkunova N; Boiteux S; Lavrik O
IUBMB Life; 2008 Feb; 60(2):130-4. PubMed ID: 18380002
[TBL] [Abstract][Full Text] [Related]
15. Induction of topoisomerase I cleavage complexes by the vinyl chloride adduct 1,N6-ethenoadenine.
Pourquier P; Bjornsti MA; Pommier Y
J Biol Chem; 1998 Oct; 273(42):27245-9. PubMed ID: 9765247
[TBL] [Abstract][Full Text] [Related]
16. Analysis of human topoisomerase I inhibition and interaction with the cleavage site +1 deoxyguanosine, via in vitro experiments and molecular modeling studies.
Laco GS; Du W; Kohlhagen G; Sayer JM; Jerina DM; Burke TG; Curran DP; Pommier Y
Bioorg Med Chem; 2004 Oct; 12(19):5225-35. PubMed ID: 15351405
[TBL] [Abstract][Full Text] [Related]
17. Sequence selectivity of the cleavage sites induced by topoisomerase I inhibitors: a molecular dynamics study.
Siu FM; Pommier Y
Nucleic Acids Res; 2013 Dec; 41(22):10010-9. PubMed ID: 24021629
[TBL] [Abstract][Full Text] [Related]
18. Structural insight of DNA topoisomerases I from camptothecin-producing plants revealed by molecular dynamics simulations.
Sirikantaramas S; Meeprasert A; Rungrotmongkol T; Fuji H; Hoshino T; Sudo H; Yamazaki M; Saito K
Phytochemistry; 2015 May; 113():50-6. PubMed ID: 25733498
[TBL] [Abstract][Full Text] [Related]
19. Position-specific trapping of topoisomerase I-DNA cleavage complexes by intercalated benzo[a]- pyrene diol epoxide adducts at the 6-amino group of adenine.
Pommier Y; Laco GS; Kohlhagen G; Sayer JM; Kroth H; Jerina DM
Proc Natl Acad Sci U S A; 2000 Sep; 97(20):10739-44. PubMed ID: 10995470
[TBL] [Abstract][Full Text] [Related]
20. Diversity of DNA topoisomerases I and inhibitors.
Pommier Y
Biochimie; 1998 Mar; 80(3):255-70. PubMed ID: 9615865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
